Przejdź do komentarzy
Przejdź do komentarzy

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 19 października 2020. Database contains 252 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

 
231-512-4
7601-90-3
Germany
Endocrine disruption
Under development
Under development
No suggestion yet
13/06/2016
Details
201-280-9
80-46-6
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/03/2017
Details
205-031-5
131-57-7
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
01/04/2015
Details
DCHP
201-545-9
84-61-7
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/09/2015
Details
216-036-7
1478-61-1
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
20/12/2018
Details
201-025-1
77-40-7
France
Endocrine disruption
Under development
Under development
No suggestion yet
07/03/2017
Details
205-029-4
131-56-6
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
205-028-9
131-55-5
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
3-benzylidene camphor; 3-BC
239-139-9
15087-24-8
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
214-946-9
1222-05-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
28/01/2020
Details
-
5436-43-1
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
Other
23/08/2019
Details
253-242-6
36861-47-9
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
253-242-6
36861-47-9
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
02/07/2020
Details
show/hide
Butan-2-one O,O',O''-(methylsilylidyne)trioxime EC / List no: 245-366-4 | CAS no: 22984-54-9
Butan-2-one O,O',O''-(vinylsilylidyne)trioxime EC / List no: 218-747-8 | CAS no: 2224-33-1
2-Pentanone, O,O',O''-(ethenylsilylidyne)trioxime EC / List no: 700-810-0 | CAS no: 58190-62-8
2-Pentanone, O,O',O''-(phenylsilylidyne)trioxime EC / List no: 700-833-6 | CAS no: 1170315-90-8
pentan-2-one O,O',O'',O'''-silanetetrayltetraoxime EC / List no: 942-139-8 | CAS no: 1170315-92-0
2-butanone-O,O',O''-(phenylsilylidyne)trioxime EC / List no: 433-360-6 | CAS no: 34036-80-1
O,O',O''-(methylsilylidyne)trioxime 2-pentanone EC / List no: 484-460-1 | CAS no: -
(E)-N-(pentan-2-ylidene)hydroxylamine EC / List no: 484-470-6 | CAS no: 623-40-5
2-Propanone, 2,2',2''-[O,O',O''-(ethylsilylidyne)trioxime] EC / List no: 611-631-1 | CAS no: 58190-57-1
Butanone oxime EC / List no: 202-496-6 | CAS no: 96-29-7
4-methylpentan-2-one oxime EC / List no: 203-298-2 | CAS no: 105-44-2
Acetone oxime EC / List no: 204-820-1 | CAS no: 127-06-0
Butan-2-one O,O',O'',O'''-silanetetrayltetraoxime EC / List no: 251-882-0 | CAS no: 34206-40-1
-
-
Germany
Carcinogenic
Under development
Under development
No suggestion yet
02/06/2020
Details
207-069-8
431-03-8
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
215-133-1
1304-56-9
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
233-660-5
10294-40-3
Netherlands
Carcinogenic
Concluded
Appropriate to initiate regulatory risk management action
CLH
SVHC
08/07/2019
Details
202-681-1
98-56-6
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details

Export search results to:

Categories Display


Route: .live2